April 2008
Indian Journal of Medical Microbiology;Apr2008, Vol. 26 Issue 2, p151
Academic Journal
No abstract available.


Related Articles

  • Paratyphoid fever in Vellore, South India. Jesudason, Mary V. // Tropical Doctor;Jul2005, Vol. 35 Issue 3, p191 

    A letter to the editor is presented to report about the paratyphoid fever in Vellore, South India.

  • Evidence for Differences in the Sexual Transmission Efficiency of HIV Strains with Distinct Drug Resistance Genotypes. de Mendoza, Carmen; Rodriguez, Carmen; Corral, Angélica; Romero, Jorge del; Gallego, Oscar; Soriano, Vincent // Clinical Infectious Diseases;10/15/2004, Vol. 39 Issue 8, p1231 

    Background. The transmission of drug-resistant human immuno deficiency virus type 1 (HIV- 1) is a matter of major concern, because it could compromise the response to antiretroviral therapy. Material and methods. From 1997 through 2003, genotypic drug resistance profiles in 89 patients with...

  • Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India. Azam, Mohd; Malik, Abida; Rizvi, Meher; Rai, Arvind // Journal of Infection in Developing Countries;Jan2014, Vol. 8 Issue 1, p79 

    Introduction: This study aimed to evaluate the prevalence of resistance mutations in the protease gene of HIV-1 strains isolated from north Indian antiretroviral (ARV) treatment-naive patients and to assess the phylogenetic relatedness of these strains with known HIV-1 strains. Methodology:...

  • Prevalence of genotypic HIV-1 drug resistance in Thailand, 2002. Ekachai Jenwitheesuk; Chotip Watitpun; Asda Vibhagool; Wasun Chantratita // Annals of Clinical Microbiology & Antimicrobials;2003, Vol. 2, p4 

    Background: The prices of reverse transcriptase (RT) inhibitors in Thailand have been reduced since December 1, 2001. It is expected that reduction in the price of these inhibitors may influence the drug resistance mutation pattern of HIV-1 among infected people. This study reports the frequency...

  • Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team). Descamps, Diane; Flandre, Philippe; Descamps, D; Flandre, P; Calvez, V; Peytavin, G; Meiffredy, V; Collin, G; Delaugerre, C; Robert-Delmas, S; Bazin, B; Aboulker, J P; Pialoux, G; Raffi, F; Brun-Vézinet, F // JAMA: Journal of the American Medical Association;1/12/2000, Vol. 283 Issue 2, p205 

    Context: In the Trilège trial, following induction with a zidovudine, lamivudine, and indinavir regimen, human immunodeficiency virus (HIV) replication was less suppressed by 2-drug maintenance therapy than by triple-drug therapy.Objective: To identify mechanisms of...

  • Análisis genético del polimorfismo del virus de la inmunodeficiencia humana en pacientes colombianos. Gómez, Alberto; Franco, Leidy; Vargas, Elisabeth; Sopó, Olga Lucía; Fajardo, Carolina; Ordóñez, Mario; Casas, María Consuelo // Universitas Médica;oct-dec2011, Vol. 52 Issue 4, p350 

    Objective: Resistance to antiretroviral drugs has been associated with characteristic mutations in the genes that encode enzymes which are the target of anti-retroviral therapy. In this paper we evaluate the different mutations revealed by molecular typing of viruses from different patients who...

  • HIV-1 Proteases from Drug-Naive West African Patients Are Differentially Less Susceptible to Protease Inhibitors. Kinomoto, Masanobu; Appiah-Opong, Regina; M. Brandful, J. A.; Yokoyama, Masaru; Nii-Trebi, Nicholas; Ugly-Kwame, Evelyn; Sato, Hironori; Ofori-Adjei, David; Kurata, Takeshi; Barre-Sinoussi, Françoise; Sata, Tetsutaro; Tokunaga, Kenzo // Clinical Infectious Diseases;7/15/2005, Vol. 41 Issue 2, p243 

    Background. Now that highly active antiretroviral therapy (HAART) is being initiated on a large scale in West Africa, it remains controversial whether protease inhibitors (PIs), originally designed and tested against human immunodeficiency virus type 1 (HIV- 1) subtype B, are equally effective...

  • The frequency of HIV-I drug resistance mutations among treatment-naïve individuals at a tertiary care centre in south India. Kandathil, A. J.; Kannangai, R.; Abraham, O. C.; Rupali, P.; Pulimood, S. A.; Verghese, V. P.; Grant, P.; Pillay, D.; Sridharan, G. // International Journal of STD & AIDS;Aug2009, Vol. 20 Issue 8, p522 

    Antiretroviral treatment (ART) use in India requires information on baseline drug resistance mutations and polymorphisms in the protease (Pr) and reverse transcriptase (RT) genes of HIV-1 strains from treatment-naïve individuals. We report resistance predictor mutations and polymorphisms in...

  • Anti-HIV-1 activity, protease inhibition and safety profile of extracts prepared from Rhus parviflora. Modi, Manoj; Nutan; Pancholi, Boskey; Kulshrestha, Shweta; Rawat, Ajay Kumar Singh; Malhotra, Swadesh; Gupta, Satish Kumar // BMC Complementary & Alternative Medicine;2013, Vol. 13 Issue 1, p158 

    Background: In the present study, extracts prepared from the leaves of Rhus parviflora Roxb. (Anacardiaceae) were evaluated for their anti-HIV activity, which have been traditionally used for the treatment of neurological disorders such as anxiety, insomnia and epilepsy. Methods: Aqueous and 50%...

  • HIV-1 genotypic diversity and prevalence of drug resistance among treatment naïve HIV-infected individuals in Chengdu of China. Zeng, Peibin; Liu, Yu; He, Miao; Gao, Zhan; Zhou, Ya; Bian, Guohui; Shan, Hua; Wang, Jingxing // Virus Genes;Dec2013, Vol. 47 Issue 3, p408 

    AIDS is becoming one of leading cause of death among infectious diseases in China. There has been rapidly increasing epidemic of HIV/AIDS in Chengdu since 2003. In order to investigate HIV-1 subtype distribution, drug resistance-associated mutations as well as drug resistance prevalence among...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics